Dr Petropoulos is an internationally recognized authority on HIV drug resistance and drug resistance technologies. His research efforts have resulted in 20 issued patents, 34 patents pending, and over 150 scientific publications. Before joining Monogram Biosciences, Dr Petropoulos directed several molecular virology laboratory groups at Genentech, one of which was focused on the development of the Company’s HIV gp120 vaccine.